Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vikky Morris
Does Fesoterodine Have a Role in the Treatment of Poorly Managed Patients With Overactive Bladder?
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
International Neurourology Journal
Neurology
Urology
Does Sacral Pulsed Electromagnetic Field Therapy Have a Better Effect Than Transcutaneous Electrical Nerve Stimulation in Patients With Neurogenic Overactive Bladder?
Arab Journal of Urology
Urology
Dealing With Complex Overactive Bladder Syndrome Patient Profiles With Focus on Fesoterodine: In or Out of the EAU Guidelines?
Research and Reports in Urology
Urology
Botulinum Toxin a for the Treatment of Overactive Bladder
Toxins
Mutagenesis
Toxicology
Health
OnabotulinumtoxinA for the Treatment of Overactive Bladder
Research and Reports in Urology
Urology
Mp65-16 Predictor Factors for Successful Treatment of Solifenacin in Patients With Overactive Bladder
Journal of Urology
Urology
Factors Associated With Dose Escalation of Fesoterodine for Treatment of Overactive Bladder in People >65 Years of Age: A Post Hoc Analysis of Data From the SOFIA Study
Neurourology and Urodynamics
Neurology
Urology
Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Prospective Study
Advances in Urology
Gynecology
Urology
Obstetrics
Transdermal Oxybutynin: What Role in the Management of Overactive Bladder?
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
